The disposition index is a quantitative measure used in endocrinology and metabolic research to assess β‑cell function relative to insulin sensitivity. It reflects the ability of pancreatic β‑cells to compensate for varying degrees of peripheral insulin resistance, thereby maintaining glucose homeostasis.
Definition and Calculation
The disposition index is defined as the product of an index of insulin secretion and an index of insulin sensitivity:
$$ \text{Disposition Index} = \text{Insulin Secretion Index} \times \text{Insulin Sensitivity Index} $$
Commonly employed components include:
| Component | Typical Metric | Description |
|---|---|---|
| Insulin secretion | First‑phase insulin response (ΔI₀–₃₀), acute insulin secretion, or C‑peptide increment | Measures the rapid release of insulin following glucose stimulation. |
| Insulin sensitivity | Matsuda index, hyperinsulinemic‑euglycemic clamp (M-value), HOMA‑IR (inverse) | Quantifies how effectively peripheral tissues respond to insulin. |
Because insulin secretion and insulin sensitivity are inversely related in normoglycemic individuals, the disposition index remains relatively constant across a range of physiologic conditions. A decline in the disposition index indicates inadequate β‑cell compensation and is predictive of progression to impaired glucose tolerance and type 2 diabetes.
Historical Context
The concept originated from studies in the 1970s and 1980s that demonstrated a hyperbolic relationship between insulin secretion and insulin sensitivity. The term “disposition index” was popularized in the 1990s, particularly through the work of Kahn and colleagues, who applied it to data from oral glucose tolerance tests (OGTT) and clamp studies.
Clinical and Research Applications
- Risk Stratification – Lower disposition index values have been shown to identify individuals at higher risk for developing type 2 diabetes, even when fasting glucose and HbA1c are normal.
- Pharmacologic Trials – The disposition index is used to evaluate the efficacy of interventions (e.g., GLP‑1 receptor agonists, thiazolidinediones) that aim to improve β‑cell function or insulin sensitivity.
- Longitudinal Cohorts – Studies such as the Diabetes Prevention Program (DPP) and the Finnish Diabetes Prevention Study have employed the disposition index to track disease progression.
- Genetic Research – Genome‑wide association studies (GWAS) sometimes use the disposition index as a phenotype to uncover genetic determinants of β‑cell compensation.
Interpretation Guidelines
- Normal Range – Values vary according to the specific metrics and population; there is no universal cut‑off. Researchers often compare individuals to a reference group matched for age, BMI, and ethnicity.
- Reduced Disposition Index – Suggests a relative deficiency in insulin secretion given the level of insulin resistance; associated with higher fasting glucose, impaired glucose tolerance, and increased diabetes incidence.
- Elevated Disposition Index – May indicate robust β‑cell compensation; observed in individuals with high insulin sensitivity (e.g., athletes) or in early insulin‑resistant states before β‑cell failure.
Limitations
- Method Dependence – Results differ based on the chosen insulin secretion and sensitivity indices; direct comparison across studies requires standardization.
- Physiological Variability – Acute factors (e.g., stress, acute illness) can transiently affect insulin secretion and sensitivity, altering the disposition index.
- Population Specificity – Reference values derived from one ethnic or age group may not be applicable to others.
Related Concepts
- HOMA‑β and HOMA‑IR – Homeostatic model assessment indices for β‑cell function and insulin resistance, respectively; these are often used in conjunction with the disposition index.
- Insulinogenic Index – Ratio of insulin increase to glucose increase during the early phase of an OGTT; it can serve as the secretion component in the disposition index calculation.
References (selected)
- Kahn SE, et al. “The Hyperbolic Relationship Between Insulin Sensitivity and Secretion: The Disposition Index.” Diabetes (1993).
- Abdul-Ghani M, et al. “Disposition Index, a Measure of β‑Cell Function, Predicts Diabetes Development.” Diabetologia (2006).
- Tisch S, et al. “Improvement of β‑Cell Function by Lifestyle Intervention: Role of the Disposition Index.” Diabetes Care (2014).
The disposition index remains a central metric for integrating insulin dynamics and is widely utilized in both clinical research and epidemiologic investigations of glucose metabolism.
